Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€22.00
28.02.24
€32.29
28.02.25
-35.80%
28.08.24

Royal Bank of Canada 
28.02.24 50%
buy
Xencor Inc.

Start price
Target price
Perf. (%)
€21.00
28.02.24
€31.37
28.02.25
-24.76%
30.08.24

BMO Capital Markets 
28.02.24 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€21.60
28.02.24
€36.02
28.02.25
-34.61%
28.08.24

Mizuho 
28.02.24 50%
buy
Xencor Inc.

Start price
Target price
Perf. (%)
€21.20
28.02.24
€31.40
28.02.25
-25.47%
30.08.24

Wedbush 
28.02.24 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€21.60
28.02.24
€33.24
28.02.25
-34.61%
28.08.24

Needham & Company LLC 
28.02.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€71.00
28.02.24
€99.73
28.02.25
-22.54%
02.09.24

Needham & Company LLC 
28.02.24 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€2.67
27.02.24
€7.38
27.02.25
-37.96%
02.09.24

Needham & Company LLC 
27.02.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€49.60
27.02.24
€81.12
27.02.25
4.84%
30.08.24

JPMorgan Chase & Co. 
27.02.24 50%
buy
Purple Biotech Ltd. ADR

Start price
Target price
Perf. (%)
€0.64
27.02.24
€9.21
27.02.25
-39.84%
30.08.24

HC Wainwright 
27.02.24 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€152.00
27.02.24
€179.60
27.02.25
16.02%
02.09.24

Citigroup Inc. 
27.02.24 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€152.00
27.02.24
€161.18
27.02.25
16.02%
02.09.24

Guggenheim 
27.02.24 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€26.80
27.02.24
€49.73
27.02.25
155.60%
30.08.24

Guggenheim 
27.02.24 50%
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€47.20
27.02.24
€82.92
27.02.25
-31.78%
19.08.24

Guggenheim 
27.02.24 50%
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€166.00
27.02.24
€317.85
27.02.25
8.43%
29.08.24

Guggenheim 
27.02.24 50%
sell
Elanco Animal Health Inc.

Start price
Target price
Perf. (%)
€15.18
27.02.24
€12.90
27.02.25
-7.89%
02.09.24

The Goldman Sachs Group, Inc. 
27.02.24 50%
buy
Elanco Animal Health Inc.

Start price
Target price
Perf. (%)
€15.18
27.02.24
€15.66
27.02.25
-7.89%
02.09.24

Morgan Stanley 
27.02.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€911.50
27.02.24
€1,091.9
27.02.25
17.39%
02.09.24

Royal Bank of Canada 
27.02.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.42
27.02.24
€9.22
27.02.25
-48.24%
02.09.24

Barclays PLC 
27.02.24 50%
buy
Elanco Animal Health Inc.

Start price
Target price
Perf. (%)
€15.18
27.02.24
€17.52
27.02.25
-7.89%
02.09.24

Barclays PLC 
27.02.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€49.60
27.02.24
€98.68
27.02.25
4.84%
30.08.24

Cantor Fitzgerald 
27.02.24 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€148.00
27.02.24
-
27.02.25
19.16%
02.09.24

William Blair 
27.02.24 50%
sell
Novan Inc

Start price
Target price
Perf. (%)
€0.001
27.02.24
-
27.02.25
-
19.09.23

StockNews.com 
27.02.24 50%
buy
Sanofi S.A. ADR

Start price
Target price
Perf. (%)
€44.60
27.02.24
-
27.02.25
18.58%
30.08.24

StockNews.com 
27.02.24 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€26.80
27.02.24
€42.39
27.02.25
155.60%
30.08.24

UBS Group AG 
27.02.24 50%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€41.52
26.02.24
€59.92
26.02.25
8.19%
02.09.24

Oppenheimer Holdings Inc. 
26.02.24 50%